media release

Akzo Nobel transfers Organon Teknika’s diagnostics business to bioMérieux

The sale to bioMérieux completes initiatives to combine Organon Teknika’s diagnostics business with a partner that would be able to enhance the position of Organon Teknika’s innovative diagnostic products in a strongly consolidating diagnostics market and provide a solid basis for the future of the business and its employees.

This transaction is one of several recent moves by Akzo Nobel to realize its Pharma strategy of growing businesses strongly focused on human pharmaceuticals, animal healthcare and biopharmaceutical production. The pharmaceutical activities of Organon Teknika have been transferred to Organon, the Pharma Group’s human pharmaceuticals business.